News and Announcements
AI-Driven Venture Capital Investing: Insights from John Sharp, Partner at Hatcher+
- Published March 28, 2023 5:25AM UTC
- Publisher Jade Miguel
- Categories Capital Insights
As the venture capital industry evolves, it’s crucial to stay on top of emerging strategies and technologies.
Join John Sharp, Partner at Hatcher +, as he shares his expertise on how venture capital has developed over time and what the future holds.
Learn about the impact of AI-driven investing strategies, historical data, and proven methodologies.
#VentureCapital #Investing #Strategy #WholesaleInvestor
Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
